Report copyright - XELJANZ (PSORIASIS) - FORECAST AND MARKET ANALYSIS TO … · Celgene’s phosphodiesterase-4 (PDE-4) inhibitor, apremilast These compounds will challenge the current biologics in
Please pass captcha verification before submit form
Please pass captcha verification before submit form